IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical Indu

CUSIP: EP0496760 | 2 institutional holders

Quarters

Q3 2016Q1 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Advent Capital Management67,321
0.4% of portfolio›$54.8K
StyleTurnoverLocationFiled
Advent Capital Management
67,321$54.8K0.4%GrowthMediumNew York, NY2016-11-22